Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-07 Brown Ryan Edward SVP, General Counsel Grant or award · Stock Option (right to buy) +48,000 48,000
2022-03-07 Ciambrone William EVP Grant or award +8,000 22,099
2022-03-07 Ciambrone William EVP Grant or award · Stock Option (right to buy) +48,000 48,000
2022-03-07 Rodino-Klapac Louise Head of R&D, CSO Grant or award +8,000 72,111
2022-03-07 Rodino-Klapac Louise Head of R&D, CSO Grant or award · Stock Option (right to buy) +48,000 48,000
2022-03-04 Estepan Ian Michael Chief Financial Officer Shares withheld for taxes −1,308 $79.20 $104K 25,069
2022-03-04 Brown Ryan Edward SVP, General Counsel Shares withheld for taxes −1,136 $79.20 $90K 18,048
2022-03-04 Ciambrone William EVP Shares withheld for taxes −1,160 $79.20 $92K 14,099
2022-03-04 Rodino-Klapac Louise Head of R&D, CSO Shares withheld for taxes −1,216 $79.20 $96K 64,111
2022-03-01 Rodino-Klapac Louise Head of R&D, CSO Shares withheld for taxes −572 $75.05 $43K 65,327
2022-03-01 Estepan Ian Michael Chief Financial Officer Shares withheld for taxes −376 $75.05 $28K 26,377
2022-03-01 Brown Ryan Edward SVP, General Counsel Shares withheld for taxes −184 $75.05 $14K 19,184
2021-12-15 BEHRENS M KATHLEEN Director Exercise or conversion +5,000 $10.08 $50K 135,517
2021-12-15 BEHRENS M KATHLEEN Director Exercise or conversion · Stock Option (Right to Buy) −5,000 0
2021-12-10 GRAY MARY ANN Director Exercise or conversion +967 9,403
2021-12-10 GRAY MARY ANN Director Exercise or conversion · Restricted Stock Units −967 0
2021-11-24 Rodino-Klapac Louise Head of R&D, CSO Purchase +3,780 $79.33 $300K 65,678
2021-11-17 INGRAM DOUGLAS S President & CEO Purchase +25,026 $79.94 $2.0M 365,082
2021-11-16 Mayo Stephen Director Grant or award +4,292 4,292
2021-11-16 Mayo Stephen Director Grant or award · Stock Option (right to buy) +8,238 8,238

Page 19 of 22 · 424 trades